Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients.
Br J Cancer
; 127(11): 2043-2051, 2022 11.
Article
de En
| MEDLINE
| ID: mdl-36192490
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs de la vessie urinaire
Type d'étude:
Diagnostic_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limites:
Humans
Langue:
En
Journal:
Br J Cancer
Année:
2022
Type de document:
Article
Pays d'affiliation:
Espagne